4D Electromagnetic Navigation Bronchoscopy for the Sampling of Pulmonary Lesions: First European Real-Life Experience.

Bronchus Sign Electromagnetic Navigation Bronchoscopy Lung Cancer Diagnosis Navigation System Pulmonary Masses Pulmonary Nodule

Journal

Lung
ISSN: 1432-1750
Titre abrégé: Lung
Pays: United States
ID NLM: 7701875

Informations de publication

Date de publication:
10 2021
Historique:
received: 27 04 2021
accepted: 12 09 2021
pubmed: 26 9 2021
medline: 27 1 2022
entrez: 25 9 2021
Statut: ppublish

Résumé

The use of Electromagnetic navigation bronchoscopy (ENB) for the diagnosis of pulmonary peripheral lesions is still debated due to its variable diagnostic yield; a new 4D ENB system, acquiring inspiratory and expiratory computed tomography (CT) scans, overcomes respiratory motion and uses tracked sampling instruments, reaching higher diagnostic yields. We aimed at evaluating diagnostic yield and accuracy of a 4D ENB system in sampling pulmonary lesions and at describing their influencing factors. We conducted a three-year retrospective observational study including all patients with pulmonary lesions who underwent 4D ENB with diagnostic purposes; all the factors potentially influencing diagnosis were recorded. 103 ENB procedures were included; diagnostic yield and accuracy were, respectively, 55.3% and 66.3%. We reported a navigation success rate of 80.6% and a diagnosis with ENB was achieved in 68.3% of cases; sensitivity for malignancy was 61.8%. The majority of lesions had a bronchus sign on CT, but only the size of lesions influenced ENB diagnosis (p < 0.05). Transbronchial needle aspiration biopsy was the most used tool (93.2% of times) with the higher diagnostic rate (70.2%). We reported only one case of pneumothorax. The diagnostic performance of a 4D ENB system is lower than other previous navigation systems used in research settings. Several factors still influence the reachability of the lesion and therefore diagnostic yield. Patient selection, as well as the multimodality approach of the lesion, is strongly recommended to obtain higher diagnostic yield and accuracy, with a low rate of complications.

Identifiants

pubmed: 34562105
doi: 10.1007/s00408-021-00477-z
pii: 10.1007/s00408-021-00477-z
pmc: PMC8510943
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

493-500

Informations de copyright

© 2021. The Author(s).

Références

Lung. 2018 Dec;196(6):721-727
pubmed: 30209566
J Thorac Dis. 2016 Jan;8(1):186-94
pubmed: 26904228
J Thorac Dis. 2020 Apr;12(4):1595-1611
pubmed: 32395297
Chest. 2020 Oct;158(4):1753-1769
pubmed: 32450240
Respiration. 2019;98(4):321-328
pubmed: 31121593
Lung Cancer Manag. 2016 Apr;5(1):9-19
pubmed: 30643545
Ann Intern Med. 2014 Mar 4;160(5):311-20
pubmed: 24379002
Ann Thorac Med. 2013 Jan;8(1):28-32
pubmed: 23440066
J Thorac Oncol. 2019 Mar;14(3):445-458
pubmed: 30476574
J Bronchology Interv Pulmonol. 2011 Apr;18(2):133-7
pubmed: 23169081
Respirology. 2019 May;24(5):453-458
pubmed: 30675961
J Bronchology Interv Pulmonol. 2012 Jul;19(3):195-9
pubmed: 23207460
Chest. 2010 Dec;138(6):1316-21
pubmed: 20435658
Respiration. 2009;78(3):293-300
pubmed: 19546519
Respir Med. 2012 May;106(5):710-5
pubmed: 22391437
Thorac Cancer. 2020 May;11(5):1191-1201
pubmed: 32130761
Respirology. 2020 Feb;25(2):206-213
pubmed: 31265204
Ann Intern Med. 2011 Aug 2;155(3):137-44
pubmed: 21810706
J Bronchology Interv Pulmonol. 2021 Jul 1;28(3):174-183
pubmed: 33369988
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
Minerva Chir. 2013 Dec;68(6):579-85
pubmed: 24193290
Chest. 2018 Jan;153(1):181-186
pubmed: 28629919
J Bronchology Interv Pulmonol. 2015 Jan;22(1):5-13
pubmed: 25590477
Respiration. 2014;87(2):165-76
pubmed: 24401166
Am J Respir Crit Care Med. 2016 Jan 1;193(1):68-77
pubmed: 26367186
J Bronchology Interv Pulmonol. 2020 Apr;27(2):106-121
pubmed: 31985505
Chest. 2007 Jun;131(6):1800-5
pubmed: 17400670

Auteurs

Filippo Patrucco (F)

Respiratory Diseases Unit, Medical Department, AOU Maggiore Della Carità, C.so Mazzini 18, 28100, Novara, Italy. filippo.patrucco@maggioreosp.novara.it.
Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy. filippo.patrucco@maggioreosp.novara.it.

Matteo Daverio (M)

Respiratory Diseases Unit, Medical Department, AOU Maggiore Della Carità, C.so Mazzini 18, 28100, Novara, Italy.

Chiara Airoldi (C)

Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.

Zeno Falaschi (Z)

Radiodiagnostics, Department of Diagnosis and Treatment Services, AOU Maggiore Della Carità, Novara, Italy.

Vittorio Longo (V)

Radiodiagnostics, Department of Diagnosis and Treatment Services, AOU Maggiore Della Carità, Novara, Italy.

Francesco Gavelli (F)

Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.

Renzo Luciano Boldorini (RL)

Pathology Unit, University of Piemonte Orientale, AOU Maggiore Della Carità, Novara, Italy.

Piero Emilio Balbo (PE)

Respiratory Diseases Unit, Medical Department, AOU Maggiore Della Carità, C.so Mazzini 18, 28100, Novara, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH